Through the past decade, Algorics has been at the forefront of data-driven drug development, helping biopharma and medical device companies achieve cost-effective and accelerated delivery of treatments to patients worldwide.
Established with a vision to improve patient outcomes through data-centric solutions, Algorics’ multidisciplinary team has successfully built a robust portfolio of innovative services coupled with next-generation technology platforms, that drive efficiencies and actionable insights. Algorics clinical data intelligence platform, Clarity is developed to maximize site, patient, and study-level insights through data analytics and visualization. With this, biopharma companies can effectively identify drug safety and efficacy trends as well as emerging issues early on. The entire Clarity ecosystem is focused on offering an independent view to study sponsors of their clinical, patient operational data.
With their other innovative platform, MetaVate, Algorics has automated metadata-driven data transformation, offering limitless possibilities to standardize enterprise-wide data, and achieve higher interoperability resulting in significant time and cost savings.
As a prominent hub for innovation, CoE actively cultivates collaborations between innovators and industry leaders, facilitating a united approach to addressing real-world development challenges. Having identified the challenges faced by a large global biopharma company and cognizing the problem-solving capabilities of Algorics, CoE made the strategic decision to establish a connection between them. The use cases in the partnership involved the application of clinical data analytics, machine learning, and data visualization to understand big data derived from their medical device portfolio. The outcomes of this program are being widely leveraged in product innovation, identifying areas of improvement, addressing pain points for patients, and enhancing overall usability.
The start-up’s clinical data science expertise along with the dynamic data analytics and visualization technology has the unique ability to leverage AI/ML algorithms to analyze large volumes of data, identify patterns, and extract valuable insights that would have been extremely challenging to achieve manually. Algorics’ extensive portfolio of data-centric solutions includes:
- Biostatistics and PK/PD services
- Statistical Programming
- Clinical Data Management
- eClinical Services
- Clinical data science and analytics
- Clarity- Clinical data intelligence platform
- MetaVate- Automated data transformation platform
In response to the ever-evolving needs of the biopharma industry, the startup has been customizing engagement models categorized under Functional Service Provision (FSP), Project-based Services, and Permanent Placements, as suited to the sponsor’s requirements. Each model has distinct advantages- for a biotech, project-based outsourcing is best-suited whereas a larger biopharma company may prefer to go with the FSP model to augment internal capacity and expertise.
Today, Algorics is supporting the Top 10 global biopharmaceutical, biotechs, medical devices companies, and CROs, across the data services spectrum. They have been active contributors to PHUSE, SCDM, ACDM, and CDISC 360, playing a pivotal role in shaping and advancing industry standards.
The startup has garnered recognition and received prestigious awards including being a Script Award Finalist, CII Entrepreneurs, Rice Alliance, and Pharma Voice 100 among others.
With a growing presence in India, the UK, and the USA, the startup is now positioned for global expansion and leveraging its innovations to improve drug development of the future.
